Early approval of vaccine possible- FDA exec

WASHINGTON, D.C.: The head of the United States Food and Drug Administration (FDA) raised the possibility in an interview published on Sunday (Monday in Manila) that a future vaccine against the coronavirus might be given emergency approval before the end of trials designed to ensure its safety and effectiveness.

A request for such extraordinary approval would have to come from the vaccine developer, Stephen Hahn told the Financial Times.